The IPO Buzz: HilleVax Hops Aboard for April’s Last Run
Vaccine maker HilleVax, Inc. (HLVX proposed) hopped on to the IPO Express early today for its last run in April 2022. This is the first sizable IPO from big banks since Excelerate Energy (EE) made its successful debut on April 13th. J.P Morgan, SVB Leerink, Stifel and Guggenheim Securities are the joint book-runners for the […]
April 25, 2022 Read More